MAS1L and Alzheimer disease: Currently, peptide polylactic glycolic acid (PLGA) nanoparticles have been reported to be loaded with MasR agonist PNA5 to treat AD across the BBB, demonstrating the potential for precise drug delivery using nanoparticles [176].